| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |